Booster doses boost antibodies, according to J&J
According to interim findings from two early-stage trials, a booster dose of Johnson & Johnson’s vaccine significantly raised antibody levels, the firm reported on Wednesday. Binding antibody levels were nine times greater following a second dose ...
26 August, 2021
Read more